Elevated pretreatment platelet-to-lymphocyte ratio is associated with poor survival in stage IV non-small cell lung cancer with malignant pleural effusion-Reference-Cited by-同舟云学术

Elevated pretreatment platelet-to-lymphocyte ratio is associated with poor survival in stage IV non-small cell lung cancer with malignant pleural effusion

Published:2019-03-18 Issue:1 Volume:9 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Lim Jeong Uk,Yeo Chang Dong,Kang Hye Seon,Park Chan Kwon,Kim Ju Sang,Kim Jin Woo,Kim Seung Joon,Lee Sang Haak^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-019-41289-9.pdf

Reference34 articles.

1. McErlean, A. & Ginsberg, M. S. Epidemiology of lung cancer. Semin Roentgenol 46, 173–177, https://doi.org/10.1053/j.ro.2011.02.002 (2011).

2. Herbst, R. S., Heymach, J. V. & Lippman, S. M. Lung cancer. N Engl J Med 359, 1367–1380, https://doi.org/10.1056/NEJMra0802714 (2008).

3. Gu, X. et al. Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: evidence from 3,430 patients. Sci Rep 6, 23893, https://doi.org/10.1038/srep23893 (2016).

4. Grivennikov, S. I., Greten, F. R. & Karin, M. Immunity. inflammation, and cancer. Cell 140, 883–899, https://doi.org/10.1016/j.cell.2010.01.025 (2010).

5. Mantovani, A., Allavena, P., Sica, A. & Balkwill, F. Cancer-related inflammation. Nature 454, 436–444, https://doi.org/10.1038/nature07205 (2008).

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. C-Reactive Protein as an Early Predictor of Efficacy in Advanced Non-Small-Cell Lung Cancer Patients: A Tumor Dynamics-Biomarker Modeling Framework;Cancers;2023-11-15

2. Pro-Tumorigenic and Thrombotic Activities of Platelets in Lung Cancer;International Journal of Molecular Sciences;2023-07-25

3. Establishment of a prognostic risk prediction modelfor non-small cell lung cancer patients with brainmetastases: a retrospective study;PeerJ;2023-07-12

4. Biological Rationale for Peripheral Blood Cell–Derived Inflammatory Indices and Related Prognostic Scores in Patients with Advanced Non-Small-Cell Lung Cancer;Current Oncology Reports;2022-10-18

5. Prognostic factors for long‐term survival following complete resection by lobectomy in stage I non‐small cell lung cancer;Thoracic Cancer;2022-08-30